SILO Pharma Inc
SILO
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.37M
Close$
$6.51
209.8% upside
Current Fair Value
209.8% upsideUndervalued by 209.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.37 Million |
|---|---|
| Enterprise Value | $-907,014.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-7.5 |
| Beta | 0.76 |
| Outstanding Shares | 1,098,517 |
Return
| Return on Equity | -91.52% |
|---|---|
| Return on Assets | -1875.04% |
| Return on Invested Capital | 547.60% |
Valuation & Multiples
| P/E Ratio | -0.39 |
|---|---|
| PEG | 1.27 |
| Price to Sales | - |
| Price to Book Ratio | -2.1 |
| Enterprise Value to Revenue | -16.77 |
| Enterprise Value to EBIT | 0.2 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$18,000
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-4.80
Average shareholder expectationRevenue Estimate
$18,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.02%▼ 7.69% |
|---|---|
| Total Invested | $61▼ 99.98% |
| Investors Holding | 1▼ 13.00% |
ESG Score
No data
About SILO Pharma Inc
1 employees